Test Overview
Enzyme-Linked Immunosorbent Assay (ELISA)
Therapeutic drug monitoring.
USTEKINUMAB QN, S: Limit of quantitation is 0.3 mcg/mL
In inflammatory bowel disease, at post-induction measurement (week 8), concentrations above 3.5 mcg/mL are associated with good outcomes
For maintenance stages:
Concentrations > or =1.0 mcg/mL are associated with clinical response and clinical remission
Concentrations > or =4.5 mcg/mL are associated with mucosal healing
USTEKINUMAB AB, S: Limit of quantitation is 10 AU/mL
Absent: <10 AU/mL
Present: > or =10 AU/mL
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Test Details
3 - 7 days
Specimen Requirements
Collect trough specimen in an SST or red top tube. Spin and aliquot serum into a screw capped plastic tube. Send to Specimen Processing refrigerated
Collect trough specimen in an SST or red top tube.
0.5 mL serum
0.4 mL serum
Additional Information
Test sent to Mayo Clinic Laboratories